-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Blueprint Medicines Corp annual/quarterly Operating Lease, Payments history and growth rate from 2019 to 2024.
- Blueprint Medicines Corp Operating Lease, Payments for the quarter ending March 31, 2024 was $4.55M, a 3.2% increase year-over-year.
- Blueprint Medicines Corp annual Operating Lease, Payments for 2024 was $18.3M, a 3.06% increase from 2023.
- Blueprint Medicines Corp annual Operating Lease, Payments for 2023 was $17.7M, a 11.6% increase from 2022.
- Blueprint Medicines Corp annual Operating Lease, Payments for 2022 was $15.9M, a 6.68% increase from 2021.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)